Wayne, PA – According to filings with the U.S. Securities and Exchange Commission, Cagent Vascular is raising $9,500,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Carol Burns played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Cagent Vascular
Cagent Vascular (Wayne, PA) has developed and has begun commercialization of its novel angioplasty balloon with Serration Technology to treat blocked arteries in the lower leg or Chronic Limb Threatening Ischemia (CLTI). This is the second cardiovascular medical device company for the co-founding team.

To learn more about Cagent Vascular, visit http://www.cagentvascular.com/

Contact:
Carol Burns, President and Chief Executive Officer
610-688-2006
cburns@cagentvascular.com
https://www.linkedin.com/in/carol-burns-339428/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved